Free Trial

Rallybio (RLYB) News Today

Rallybio logo
$0.60 +0.01 (+2.39%)
As of 12:14 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RLYB Latest News

Rallybio Granted Extension for Nasdaq Compliance
TD Cowen Reaffirms Their Buy Rating on Rallybio (RLYB)
Evercore ISI Remains a Hold on Rallybio (RLYB)
Jones Trading Downgrades Rallybio (RLYB)
Rallybio downgraded to Hold from Buy at JonesResearch
Rallybio downgraded to In Line from Outperform at Evercore ISI
Rallybio (RLYB) was downgraded to a Hold Rating at H.C. Wainwright
Rallybio discontinues RLYB212 program
Citizens JMP downgrades Rallybio on RLYB212 discontinuation
JMP Securities downgrades Rallybio (RLYB) to a Hold
Rallybio reports Q4 EPS (25c), consensus (30c)
JMP Securities Sticks to Their Buy Rating for Rallybio (RLYB)
Rallybio announces initiation of dosing in RLYB212 Phase 2 trial
Rallybio price target lowered to $7 from $8 at JMP Securities
TD Cowen Keeps Their Buy Rating on Rallybio (RLYB)
Rallybio Flat on Release of New Findings
Get Rallybio News Delivered to You Automatically

Sign up to receive the latest news and ratings for RLYB and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RLYB Media Mentions By Week

RLYB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RLYB
News Sentiment

0.53

0.71

Average
Medical
News Sentiment

RLYB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RLYB Articles
This Week

4

1

RLYB Articles
Average Week

Get the Latest News and Ratings for RLYB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Rallybio and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:RLYB) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners